Skip to content

All recalls FDA

FDADrugsRecalled Status: Closed by the agency

Golden State Medical Supply Inc. recalls Duloxetine Delayed-Release Capsules

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the proposed interim limit.
Products
  • Duloxetine Delayed-Release Capsules
Where it was sold

Nationwide in the U.S.

Nationwide

Units affected
21,655 (30 count bottle), 34,149 (90 count bottle)
About this recall
Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, NDC 60429-165-30; b) 90 capsules bottles, NDC 60429-165-90, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Packaged by GSMS, Incorporated, Camarillo, CA 93012.